NOF (4403) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
11 May, 2026Executive summary
Net sales rose 8.2% year-over-year to ¥257,967 million, with operating profit up 4.6% and profit attributable to owners of parent up 11.1%.
Growth was driven by business expansion in prioritized fields and cost reduction efforts, despite global economic uncertainties and high raw material prices.
The company advanced its solutions-based business model and launched open innovation initiatives in electronics.
Financial highlights
Net sales: ¥257,967 million (+8.2% YoY); Operating profit: ¥47,411 million (+4.6% YoY); Ordinary profit: ¥50,366 million (+8.1% YoY); Profit attributable to owners of parent: ¥40,550 million (+11.1% YoY).
Basic earnings per share: ¥176.34 (vs. ¥153.88 prior year).
Total assets: ¥399,168 million; Net assets: ¥296,465 million; Equity-to-asset ratio: 74.0%.
Cash and cash equivalents at period end: ¥82,973 million.
Annual dividend: ¥61 per share; payout ratio: 34.6%.
Outlook and guidance
FY2027 forecast: Net sales ¥319,000 million (+23.7% YoY), operating profit ¥50,000 million (+5.5%), ordinary profit ¥51,000 million (+1.3%), profit attributable to owners of parent ¥39,000 million (−3.8%), EPS ¥169.60.
Segment outlook: Functional Chemicals and Pharmaceuticals expect higher revenue but lower profit; Explosives & Propulsion expects significant growth in both revenue and profit.
Annual dividend forecast for FY2027: ¥70 per share.
Latest events from NOF
- Net sales up, profits down; strong explosives growth; dividend and share buyback increased.4403
Q3 202613 Feb 2026 - Profits fell but full-year outlook and shareholder returns were raised on segment growth.4403
Q2 202618 Nov 2025 - Net sales rose slightly, but profits declined amid global uncertainty and higher costs.4403
Q1 20266 Aug 2025 - Sales and profits climbed in H1 FY2024, with guidance and shareholder returns both increased.4403
Q2 202513 Jun 2025 - Strong Q1 profit growth driven by Functional Chemicals; full-year outlook maintained.4403
Q1 202513 Jun 2025 - Record profits, higher dividends, and robust capital returns drive future growth.4403
Q4 20256 Jun 2025 - Sales and profits rose, driven by Functional Chemicals, with stable outlook and shareholder returns.4403
Q3 20255 Jun 2025